Fig. 2From: Efficacy and safety of novel oral anticoagulants in patients with atrial nonvalvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysisForest plot of the risk of stroke/systemic embolism among NVAF patients with diabetes on DOACs versus warfarinBack to article page